Between 2000 and 2016 in the UK, the recorded prevalence of atrial fibrillation increased, accompanied by a significant improvement in appropriate anticoagulant prescribing for eligible patients.
Answers are grounded in this paper and cite their sources.
Rising AF prevalence with improved anticoagulation may support wider detection; extends UK trends but leaves open outcome benefits.
From 2000 to 2016, the prevalence of recorded AF has increased in all age groups and both sexes. Anticoagulant treatment of eligible patients with AF has more than doubled, with marked improvements since 2011, alongside a reduction in the use of anticoagulants in ineligible patients with AF.
No takes yet. Share an insight, caveat, or question.
Adderley et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: